Company: BIAF
Filing Date: 2025-05-23
Form Type: PRER14A
Source: 0001641172-25-012315
Chunk: 57

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-23
Form: PRER14A
Chunk 57
---
 Increase Proposal, and/or the Anti-Dilution Adjustment Proposal and use the additional time to solicit the holders of those shares to change their vote in favor of the Reverse Stock Split Proposal, the Warrant Exercise Proposal, the Authorized Increase Proposal, and/or the Anti-Dilution Adjustment Proposal.

Interests of Directors and Executive Officers

Our directors and executive officers have no substantial interests, directly or indirectly, in the matters set forth in this proposal. However, as a condition to the closing of the best efforts public offering on May 7, 2025, our officers and directors executed support agreements, agreeing to vote in support of this Proposal No. 7, as well as the Authorized Increase Proposal (Proposal No. 5) and the Anti-Dilution Adjustment Proposal (Proposal No. 6).

Vote Required

The affirmative vote of the holders of a majority of the shares present in person or represented by proxy at the Annual Meeting is required to approve the Adjournment Proposal. Abstentions will have the same effect as a vote AGAINST the proposal. Broker non-votes are not expected for this proposal because we believe this matter is a routine matter. If there were to be any broker non-votes they would have no effect on this proposal.

| 29 |

<div align='center'>THE BOARD UNANIMOUSLY RECOMMENDS A

VOTE “FOR” APPROVAL OF THE ADJOURNMENT PROPOSAL.

DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</div>

The following is a list of the Company’s directors and executive officers as of May 29, 2025. As set forth in Proposal No. 1, seven of the Company’s eight current directors have been nominated for re-election to the Board and will be submitted to the vote of the Company’s stockholders at the Annual Meeting. Mr. Stuart Diamond is not seeking re-election.

| Name            |     | Age |     | Position(s)                                    |
| Maria           
 Zannes, JD      |     |  69 |     | President,                                     
 CEO, and Director                              |
| James           
 Michael Edwards |     |  58 |     | Chief                                          
 Financial Officer                              |
| Xavier          
 Reveles         |     |  56 |     | Chief                                          
 Operating Officer                              |
| Timothy         
 P. Zannes, JD   |     |  72 |     | Executive                                      
 Vice President, Secretary, and General Counsel |
| Steven          
 Girgenti